In 2025, CDG Invest Growth invested alongside Mediterrania Capital Partners in Dislog Medical Devices (“DMD”), a leading player in the Moroccan medical devices sector and a subsidiary of Dislog Group, through a capital increase.

This partnership reflects CDG Invest Growth’s commitment to supporting the development of DMD, particularly through a build-up strategy already successfully launched by Dislog Group. The shared ambition is to build a national and regional leader in the medical devices market.

Founded in March 2025, Dislog Medical Devices brings together all of Dislog Group’s medical device distribution activities. These are currently run through five recently acquired companies: Afrobiomedic, Eramedic, Farmalac, Megaflex and ScoMedica. DMD operates across several key medical areas, including laboratories, endoscopy and gastroenterology, cardiology, and pharmaceutical packaging.